Spirea


Programme

Accelerate alumni

Sector

Healthcare/Pharma/Biotech



Logo spirea
Programme
Accelerate Alumni (Cohort 4)
Founded in
2017
Total funds raised
£2.9 million
Employees
1-10
Industry
Healthcare, pharma, biotech

Spirea, a spin-out from the University of Cambridge, is developing the next generation of antibody drug conjugate cancer therapeutics which carry more drug payload to tumour cells resulting in greater efficacy and tolerability and the ability to treat more cancer patients.

Get in touch

Visit Spirea's website

Top